Shares of Protagenic Therapeutics, Inc. (PTIX) more than doubled on Thursday morning, after the biopharmaceutical company announced progress in its clinical trial for PT00114, a therapy targeting stress and mood disorders. PTIX is currently trading at $4.96, up $2.68 or 117.56%, on the Nasdaq. The...
Shares of Protagenic Therapeutics Inc. (PTIX) are up over 160% at $7.70 in premarket trading Monday, on news of the company's business combination with Phytanix Bio Inc. in an all-stock transaction.
Here is a list of biotech stocks which are making strong moves in Monday's pre-market trading (as of 8.20 A.M. ET).
Listed below are some of the biotech stocks that have shown notable activity in pre-market trading Thursday, as of 8.05 a.m. ET.
Some of the biotech stocks making significant moves in Tuesday's pre-market are as follows (as of 7.45 A.M. ET).
August 13, 2026 05:33 ET The World Health Organization’s cancer research agency, the International Agency for Research on Cancer (IARC), has classified three widely used medicines as carcinogenic to humans.